IMARC Group, a leading market research company, has recently released a report titled “Connected Drug Delivery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global connected drug delivery devices market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How Big is the Connected Drug Delivery Devices Market?

The global connected drug delivery devices market size reached US$ 652.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 3,517.0 Million by 2028, exhibiting a growth rate (CAGR) of 33.6% during 2023-2028.

What is Connected Drug Delivery Devices?

Connected drug delivery devices represent a significant advancement in the field of medical technology, offering enhanced patient care and adherence to prescribed treatments. These devices are equipped with smart technology, such as Bluetooth or Wi-Fi capabilities, which allows them to connect with digital platforms for monitoring and managing medication regimes. The primary feature of connected drug delivery devices is their ability to track and record the usage of medication, providing valuable data for both patients and healthcare providers.

Request For a PDF Sample Report: https://www.imarcgroup.com/connected-drug-delivery-devices-market/requestsample

What are the Growth Prospects and Trends in the Connected Drug Delivery Devices Industry?

The key driver for the market growth of connected drug delivery devices is the increasing prevalence of chronic diseases, which require strict adherence to medication schedules. This adherence is crucial in managing conditions such as diabetes, asthma, and cardiovascular diseases. The integration of smart technology into drug delivery devices significantly aids in ensuring that patients take their medications as prescribed, thereby improving overall treatment outcomes.

Moreover, the rising focus on personalized healthcare and patient-centric approaches is fueling the market growth. Innovation in healthcare technology is another major factor contributing to the growth of this market. Technological advancements are leading to the development of more sophisticated and user-friendly devices, making it easier for patients to manage their treatments. Furthermore, these devices often come with companion mobile applications, which offer features such as reminders, usage history, and data sharing with healthcare providers.

Furthermore, the collaboration between technology developers and pharmaceutical companies is leading to more advanced and efficient drug delivery systems. These collaborations are focusing on enhancing the functionality of connected devices, improving patient engagement, and ensuring the devices are intuitive and easy to use. The integration of connected drug delivery devices into various therapeutic areas, ranging from chronic disease management to post-operative care, is also a key factor in market growth.

Who are the Key Players Operating in the Connected Drug Delivery Devices Market?

The competitive landscape of the industry has also been examined along with the profiles of the key players.

• Adherium Ltd.
• BioCorp Production
• Cohero Health Inc. (AptarGroup Inc.)
• Elcam Medical ACS. Ltd
• Findair Sp. z o. o.
• Merck KGaA
• Phillips Medisize (Molex LLC)
• Propeller Health (Resmed Inc.)
• Teva Pharmaceutical Industries Ltd.
• West Pharmaceutical Services Inc.

What is Included in Market Segmentation?

The report has categorized the market based on product, end user, technology and region.

Breakup by Product:

• Connected Sensors
  • Connected Inhaler Sensors
  • Connectable Injection Sensors
• Integrated Connected Devices
  • Connected Inhalation Devices
  • Connected Injection Devices

Breakup by End User:

• Hospitals and Healthcare Providers
• Homecare

Breakup by Technology:

• Bluetooth
• NFC
• Others

Regional Insights:

• North America
• Europe 
• Asia Pacific
• Latin America
• Middle East and Africa

Ask Analyst for Customization and Explore full report with TOC List of Figures: https://www.imarcgroup.com/request?type=reportid=3738flag=C

Key Highlights of the Report:                                                    

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:

Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com